The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Screening for breast cancer with mammography
Open accessAbstract
BACKGROUND: A variety of estimates of the benefits and harms of mammographic screening for breast cancer have been published and national policies vary. OBJECTIVES: To assess the effect of screening for breast cancer with mammography on mortality and morbidity. SEARCH METHODS: We searched PubMed (22 November 2012) and the World Health Organization's International Clinical Trials Registry Platform (22 November 2012). SELECTION CRITERIA: Randomised trials comparing mammographic screening with no mammographic screening. DATA COLLECTION AND ANALYSIS: Two authors independently extracted data. Study authors were contacted for additional information. MAIN RESULTS: Eight eligible trials were identified. We excluded a trial because the randomisation had failed to produce comparable groups.The eligible trials included 600,000 women in the analyses in the age range 39 to 74 years. Three trials with adequate randomisation did not show a statistically significant reduction in breast cancer mortality at 13 years (relative risk (RR) 0.90, 95% confidence interval (CI) 0.79 to 1.02); four trials with suboptimal randomisation showed a significant reduction in breast cancer mortality with an RR of 0.75 (95% CI 0.67 to 0.83). The RR for all seven trials combined was 0.81 (95% CI 0.74 to 0.87). We found that breast cancer mortality was an unreliable outcome that was biased in favour of screening, mainly because of differential misclassification of cause of death. The trials with adequate randomisation did not find an effect of screening on total cancer mortality, including breast cancer, after 10 years (RR 1.02, 95% CI 0.95 to 1.10) or on all-cause mortality after 13 years (RR 0.99, 95% CI 0.95 to 1.03).Total numbers of lumpectomies and mastectomies were significantly larger in the screened groups (RR 1.31, 95% CI 1.22 to 1.42), as were number of mastectomies (RR 1.20, 95% CI 1.08 to 1.32). The use of radiotherapy was similarly increased whereas there was no difference in the use of chemotherapy (data available in only two trials). AUTHORS' CONCLUSIONS: If we assume that screening reduces breast cancer mortality by 15% and that overdiagnosis and overtreatment is at 30%, it means that for every 2000 women invited for screening throughout 10 years, one will avoid dying of breast cancer and 10 healthy women, who would not have been diagnosed if there had not been screening, will be treated unnecessarily. Furthermore, more than 200 women will experience important psychological distress including anxiety and uncertainty for years because of false positive findings. To help ensure that the women are fully informed before they decide whether or not to attend screening, we have written an evidence-based leaflet for lay people that is available in several languages on www.cochrane.dk. Because of substantial advances in treatment and greater breast cancer awareness since the trials were carried out, it is likely that the absolute effect of screening today is smaller than in the trials. Recent observational studies show more overdiagnosis than in the trials and very little or no reduction in the incidence of advanced cancers with screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · The Use of Human Cells for the Evaluation of Risk from Physical and Chemical Agents · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,501
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Cited by
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00008 · Cited by 1,686
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., Zackrisson, S., & Cardoso, F. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv298 · Cited by 1,597
Helping Doctors and Patients Make Sense of Health Statistics
Gigerenzer, G., Gaissmaier, W., Kurz-Milcke, E., Schwartz, L. M., & Woloshin, S. (2007) · Psychological Science in the Public Interest · doi:10.1111/j.1539-6053.2008.00033.x · Cited by 1,336
Early Detection of Prostate Cancer: AUA Guideline
Carter, H. B., Albertsen, P. C., Barry, M. J., Etzioni, R., Freedland, S. J., Greene, K. L., Holmberg, L., Kantoff, P., Konety, B. R., Murad, M. H., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.04.119 · Cited by 1,242
Elmore, J. G. (2005) · JAMA · doi:10.1001/jama.293.10.1245 · Cited by 1,075
Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.177 · Cited by 1,069
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
Hugosson, J., Carlsson, S., Aus, G., Bergdahl, S., Khatami, A., Lodding, P., Pihl, C.-G., Stranne, J., Holmberg, E., & Lilja, H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70146-7 · Cited by 936
Moynihan, R., G⊘tzsche, P. C., Heath, I., & Henry, D. (2002) · BMJ · doi:10.1136/bmj.324.7342.886 · Cited by 900
Self-citationInternational Variation in Female Breast Cancer Incidence and Mortality Rates
DeSantis, C. E., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B. O., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0535 · Cited by 804
Tabár, L., Vitak, B., Chen, T. H.-H., Yen, A. M.-F., Cohen, A., Tot, T., Chiu, S. Y.-H., Chen, S. L.-S., Fann, J. C.-Y., Rosell, J., et al. (2011) · Radiology · doi:10.1148/radiol.11110469 · Cited by 791
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770
Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
Elmore, J. G., Longton, G. M., Carney, P. A., Geller, B. M., Onega, T., Tosteson, A. N. A., Nelson, H. D., Pepe, M. S., Allison, K. H., Schnitt, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.1405 · Cited by 751
Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices
Prasad, V., & Ioannidis, J. P. (2014) · Implementation Science · doi:10.1186/1748-5908-9-1 · Cited by 723
Cochrane review on screening for breast cancer with mammography
Olsen, O., & Gøtzsche, P. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06449-2 · Cited by 710
Self-citationYoulden, D. R., Cramb, S. M., Dunn, N. A. M., Muller, J. M., Pyke, C. M., & Baade, P. D. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.02.007 · Cited by 709
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Hugosson, J., Roobol, M. J., Månsson, M., Tammela, T. L. J., Zappa, M., Nelen, V., Kwiatkowski, M., Lujan, M., Carlsson, S. V., Talala, K. M., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.02.009 · Cited by 698
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2015.13183 · Cited by 637
Nelson, H. D., Fu, R., Cantor, A., Pappas, M., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0969 · Cited by 611
The expanding role of primary care in cancer control
Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J., Fahey, T., Grassi, L., Grunfeld, E., Gupta, S., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00205-3 · Cited by 555
Lay health workers in primary and community health care
Lewin, S., Dick, J., Pond, P., Zwarenstein, M., Aja, G. N., van Wyk, B. E., Bosch-Capblanch, X., & Patrick, M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004015.pub2 · Cited by 544
Limitations of the Randomized Controlled Trial in Evaluating Population-Based Health Interventions
Sanson-Fisher, R. W., Bonevski, B., Green, L. W., & D’Este, C. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.04.007 · Cited by 514
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
RetractedEffect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
Rethinking Screening for Breast Cancer and Prostate Cancer
Esserman, L. (2009) · JAMA · doi:10.1001/jama.2009.1498 · Cited by 516
Jorgensen, K. J., & Gotzsche, P. C. (2009) · BMJ · doi:10.1136/bmj.b2587 · Cited by 502
Broeders, M., Moss, S., Nyström, L., Njor, S., Jonsson, H., Paap, E., Massat, N., Duffy, S., Lynge, E., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012078 · Cited by 489
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Zackrisson, S., & Cardoso, F. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt284 · Cited by 479
A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions
Pace, L. E., & Keating, N. L. (2014) · JAMA · doi:10.1001/jama.2014.1398 · Cited by 461
Screening programmes for the early detection and prevention of oral cancer
Brocklehurst, P., Kujan, O., O'Malley, L., Ogden, G. R., Shepherd, S., & Glenny, A.-M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004150.pub4 · Cited by 459
MRI for breast cancer screening, diagnosis, and treatment
Morrow, M., Waters, J., & Morris, E. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61350-0 · Cited by 448
Jørgensen, A. W., Hilden, J., & Gøtzsche, P. C. (2006) · BMJ · doi:10.1136/bmj.38973.444699.0b · Cited by 444
Self-citationChallenges to the early diagnosis and treatment of breast cancer in developing countries
Unger-Saldaña, K. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.465 · Cited by 439
Effects of Age on the Detection and Management of Breast Cancer
McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M. (2015) · Cancers · doi:10.3390/cancers7020815 · Cited by 374
Regular self-examination or clinical examination for early detection of breast cancer
Kösters, J. P., & Gøtzsche, P. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003373 · Cited by 372
Self-citationBenefits and harms of mammography screening
Løberg, M., Lousdal, M. L., Bretthauer, M., & Kalager, M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0525-z · Cited by 368
Recommendations on screening for breast cancer in average-risk women aged 40-74 years
The Canadian Task Force on Preventive Health Care (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110334 · Cited by 348
Personalised risk communication for informed decision making about taking screening tests
Edwards, A. G., Naik, G., Ahmed, H., Elwyn, G. J., Pickles, T., Hood, K., & Playle, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001865.pub3 · Cited by 331
Pathogenesis, prevention, diagnosis and treatment of breast cancer
Shah, R. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.283 · Cited by 329
Schousboe, J. T., Kerlikowske, K., Loh, A., & Cummings, S. R. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-1-201107050-00003 · Cited by 317
Nothacker, M., Duda, V., Hahn, M., Warm, M., Degenhardt, F., Madjar, H., Weinbrenner, S., & Albert, U.-S. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-335 · Cited by 314
Montazeri, A., Vahdaninia, M., Harirchi, I., Harirchi, A., Sajadian, A., Khaleghi, F., Ebrahimi, M., Haghighat, S., & Jarvandi, S. (2008) · Asia Pacific Family Medicine · doi:10.1186/1447-056x-7-6 · Cited by 312
Microwave Breast Imaging: Clinical Advances and Remaining Challenges
O’Loughlin, D., O’Halloran, M., Moloney, B. M., Glavin, M., Jones, E., & Elahi, M. A. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2018.2809541 · Cited by 307
Coronary Artery Calcium Scanning
Hecht, H. S. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.02.006 · Cited by 305
Screening for Cancer in Low- and Middle-Income Countries
Sankaranarayanan, R. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2014.09.014 · Cited by 296
Diagnosing Tests: Using and Misusing Diagnostic and Screening Tests
Streiner, D. L. (2003) · Journal of Personality Assessment · doi:10.1207/s15327752jpa8103_03 · Cited by 300
Current State of Breast Cancer Diagnosis, Treatment, and Theranostics
Bhushan, A., Gonsalves, A., & Menon, J. U. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050723 · Cited by 298
Breast cancer screening in developing countries
da Costa Vieira, R. A., Biller, G., Uemura, G., Ruiz, C. A., & Curado, M. P. (2017) · Clinics · doi:10.6061/clinics/2017(04)09 · Cited by 293
Cancer surveillance in patients with primary sclerosing cholangitis
Razumilava, N., Gores, G. J., & Lindor, K. D. (2011) · Hepatology · doi:10.1002/hep.24570 · Cited by 292
Li-Fraumeni syndrome: cancer risk assessment and clinical management
McBride, K. A., Ballinger, M. L., Killick, E., Kirk, J., Tattersall, M. H. N., Eeles, R. A., Thomas, D. M., & Mitchell, G. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.41 · Cited by 281
Mandelblatt, J. S., Stout, N. K., Schechter, C. B., van den Broek, J. J., Miglioretti, D. L., Krapcho, M., Trentham-Dietz, A., Munoz, D., Lee, S. J., Berry, D. A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1536 · Cited by 281
On the Supposed Evidence for Libertarian Paternalism
Gigerenzer, G. (2015) · Review of Philosophy and Psychology · doi:10.1007/s13164-015-0248-1 · Cited by 276
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
Esserman, L. J., the WISDOM Study and Athena Investigators, Anton-Culver, H., Borowsky, A., Brain, S., Cink, T., Crawford, B., Eklund, M., Esserman, L., Fenton, J., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0035-5 · Cited by 272
Benson, J. R., Jatoi, I., Keisch, M., Esteva, F. J., Makris, A., & Jordan, V. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60316-0 · Cited by 261
Screening for Breast Cancer in 2018—What Should We be Doing Today?
Seely, J. M., & Alhassan, T. (2018) · Current Oncology · doi:10.3747/co.25.3770 · Cited by 258
Screening for Pancreatic Cancer: Why, How, and Who?
Poruk, K. E., Firpo, M. A., Adler, D. G., & Mulvihill, S. J. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31825ffbfb · Cited by 249
Review of multimodal machine learning approaches in healthcare
Krones, F., Marikkar, U., Parsons, G., Szmul, A., & Mahdi, A. (2025) · Information Fusion · doi:10.1016/j.inffus.2024.102690 · Cited by 235
Evidence Of Evidence-Based Health Policy: The Politics Of Systematic Reviews In Coverage Decisions
Fox, D. M. (2005) · Health Affairs · doi:10.1377/hlthaff.24.1.114 · Cited by 123
68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer
Zhang, J., Mao, F., Niu, G., Peng, L., Lang, L., Li, F., Ying, H., Wu, H., Pan, B., Zhu, Z., et al. (2018) · Theranostics · doi:10.7150/thno.22601 · Cited by 95
Ritchie, D., Van den Broucke, S., & Van Hal, G. (2021) · Public Health Nursing · doi:10.1111/phn.12842 · Cited by 87
Mc Cord, K. A., Ewald, H., Agarwal, A., Glinz, D., Aghlmandi, S., Ioannidis, J. P. A., & Hemkens, L. G. (2021) · BMJ · doi:10.1136/bmj.n450 · Cited by 61
Social disparities in access to breast and cervical cancer screening by women living in Spain
Ricardo-Rodrigues, I., Jiménez-García, R., Hernández-Barrera, V., Carrasco-Garrido, P., Jiménez-Trujillo, I., & López de Andrés, A. (2015) · Public Health · doi:10.1016/j.puhe.2015.02.021 · Cited by 54
Talley, C. H., Yang, L., & Williams, K. P. (2017) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-016-0355-9 · Cited by 41
COŞKUN, D., KARABOĞA, D., BAŞTÜRK, A., AKAY, B., NALBANTOĞLU, Ö. U., DOĞAN, S., PAÇAL, İ., & KARAGÖZ, M. A. (2023) · Turkish Journal of Electrical Engineering and Computer Sciences · doi:10.55730/1300-0632.4048 · Cited by 38
Vedel, I., Puts, M. T. E., Monette, M., Monette, J., & Bergman, H. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2010.11.003 · Cited by 30
Ritchie, D., Van Hal, G., & Van den Broucke, S. (2022) · Archives of Public Health · doi:10.1186/s13690-022-00902-6 · Cited by 11
Metadata
- Authors
- Gøtzsche, P. C., & Jørgensen, K. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-06-04
- Volume
- 2013
- Issue
- 6
- Pages
- CD001877-CD001877
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1549906179
- Cited by
- 1,869
- References
- 167
- FWCI
- 93.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.